
Barclays’s latest rating for HUMA stock
Humacyte Inc’s recently made public that its Director Dougan Brady W unloaded Company’s shares for reported $1.79 million on Aug
Humacyte Inc’s recently made public that its Director Dougan Brady W unloaded Company’s shares for reported $1.79 million on Aug
In a filing, Humacyte Inc revealed its Director Dougan Brady W unloaded Company’s shares for reported $1.79 million on Aug
In a filing, Humacyte Inc revealed its Director Dougan Brady W unloaded Company’s shares for reported $1.79 million on Aug
Humacyte Inc’s recently made public that its Director AYABUDGE LLC acquired Company’s shares for reported $1.0 million on Aug 18
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Humacyte Inc
Humacyte Inc’s recent filing unveils that its Chief Commercial Officer Scheessele William John acquired Company’s shares for reported $9999.0 on
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
Humacyte Inc’s recent filing unveils that its Chief Commercial Officer Scheessele William John acquired Company’s shares for reported $9999.0 on
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Humacyte Inc